FDA Drug Recalls

Recalls / Class II

Class IID-606-2013

Product

Actiq (oral transmucosal fentanyl citrate) 200 mcg, lozenge on a stick, a)Single Blister (NDC 63459-502-01), b) 30 count carton (NDC 63459-502-30), Rx only, Manufactured by: Cephalon, Inc., Salt Lake City, UT 84116

Affected lot / code info
Lot C88583, exp. 06/15

Why it was recalled

Failed Dissolution Specification; during stability testing

Recalling firm

Firm
Teva Pharmaceuticals USA, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
650 Cathill Rd, Sellersville, Pennsylvania 18960-1512

Distribution

Quantity
316 cartons
Distribution pattern
Product was distributed within the United States to FL, IL, MA, MO, MS, OH and TX. No government or foreign distribution.

Timeline

Recall initiated
2013-05-28
FDA classified
2013-06-19
Posted by FDA
2013-06-26
Terminated
2014-07-23
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-606-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.